ARTES Biotechnology GmbH products

ARTES’ METAVAX® platform is designed for the development of highly immunogenic subunit vaccines in human and animal health. It is based on enveloped virus like particles (VLP) derived from the recombinant surface antigen of the duck hepatitis B virus (dS) as scaffold.